Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4562-4562
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges
Yuchu Xiang, Xudong Liu, Yifan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 30
Activities against Lung Cancer of Biosynthesized Silver Nanoparticles: A Review
Jorge L. Mejía-Méndez, Edgar R. López-Mena, Eugenio Sánchez-Arreola
Biomedicines (2023) Vol. 11, Iss. 2, pp. 389-389
Open Access | Times Cited: 21
Nanozymes with biomimetically designed properties for cancer treatment
Ke Xu, Yujie Cui, Bin Guan, et al.
Nanoscale (2024) Vol. 16, Iss. 16, pp. 7786-7824
Open Access | Times Cited: 10
PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges
Jiyun Zhang, Miru Tang, Jinsai Shang
Biomolecules (2024) Vol. 14, Iss. 2, pp. 190-190
Open Access | Times Cited: 8
Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
Pankaj Garg, Sulabh Singhal, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4189-4189
Open Access | Times Cited: 7
Traversing through the Mechanistic Event Analysis in IL-6 and IL-17 Signaling for a New Therapeutic Paradigm in NSCLC
Riya Khilwani, Shailza Singh
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1216-1216
Open Access | Times Cited: 6
Social and Biological Determinants in Lung Cancer Disparity
Briana A. Brock, Hina Mir, Eric L. Flenaugh, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 612-612
Open Access | Times Cited: 5
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Masaud Shah, Muhammad Hussain, Hyun Goo Woo
Genomics & Informatics (2025) Vol. 23, Iss. 1
Open Access
A Pilot Study on Qualitative Metabolomics to Characterize Lewis Lung Carcinoma in Mice
Agnieszka Stawarska, Magdalena Bamburowicz‐Klimkowska, Dariusz Maciej Pisklak, et al.
Life (2025) Vol. 15, Iss. 2, pp. 202-202
Open Access
Advanced Biomarkers and Precision Medicine: Innovative Strategies to Prevent Cancer Recurrence
MS Ganesh, R. Revanth, C. Mahesh Elaya Bharathi
Journal of cancer research updates (2025) Vol. 14, pp. 1-11
Closed Access
Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Calcium Sulfide Nanoclusters Trigger DNA Damage and Induce Cell Cycle Arrest in Non-Small-Cell Lung Adenocarcinoma Cells
Maria Figueroa, Kevin Muñoz Forti, Patricia C. Rodríguez-Rodríguez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1665-1665
Open Access
Exploring manzamine a: a promising anti-lung cancer agent from marine sponge Haliclona sp
Su Min, Jie Zhu, Lu Bai, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
β-elemene: A promising natural compound in lung cancer therapy
Jiguang Bao, Zhiliang Li, D Zhang
European Journal of Pharmacology (2025), pp. 177399-177399
Closed Access
Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways
Pratik Mohanty, Babita Pande, Rakesh Kumar Acharya, et al.
(2024)
Open Access | Times Cited: 4
Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways
Pratik Mohanty, Babita Pande, Rakesh Kumar Acharya, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 93-93
Open Access | Times Cited: 4
Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
Phaedra C. Ghazi, Kayla O’Toole, Sanjana Srinivas Boggaram, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 4
BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy
Shivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy
Allana Carvalho Silva, Mirsiane Pascoal Costa, Thiago Medeiros Zacaron, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 969-969
Open Access | Times Cited: 3
Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment
Mahesh Koirala, Mario DiPaola
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1801-1801
Open Access | Times Cited: 3
Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
Phaedra C. Ghazi, Kayla O’Toole, Sanjana Srinivas Boggaram, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 3
Apoptosis-targeted gene therapy for non-small cell lung cancer using chitosan-poly-lactic-co-glycolic acid -based nano-delivery system and CASP8 and miRs 29A-B1 and 34A
Sourav Chattopadhyay, Shashanka Shekhar Sarkar, Sheetanshu Saproo, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 9
Epigenetic regulation of pulmonary inflammation
Shama Ahmad, Xiao Lu Zhang, Aftab Ahmad
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 346-354
Closed Access | Times Cited: 8
Cisplatin-based Liposomal Nanocarriers for Drug Delivery in Lung Cancer Therapy: Recent Progress and Future Outlooks
Kave Mohammad-Jafari, Seyed Morteza Naghib, M. R. Mozafari
Current Pharmaceutical Design (2024) Vol. 30, Iss. 36, pp. 2850-2881
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top